Michael D. Clayman - Net Worth and Insider Trading
Michael D. Clayman Net Worth
The estimated net worth of Michael D. Clayman is at least $8 Million dollars as of 2024-11-13. Michael D. Clayman is the President and CEO of Flexion Therapeutics Inc and owns about 824,845 shares of Flexion Therapeutics Inc (FLXN) stock worth over $8 Million. Details can be seen in Michael D. Clayman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael D. Clayman has not made any transactions after 2020-05-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael D. Clayman
Michael D. Clayman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael D. Clayman owns 2 companies in total, including Flexion Therapeutics Inc (FLXN) , and Akebia Therapeutics Inc (AKBA) .
Click here to see the complete history of Michael D. Clayman’s form 4 insider trades.
Insider Ownership Summary of Michael D. Clayman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FLXN | Flexion Therapeutics Inc | 2020-07-16 | director & President and CEO |
| AKBA | Akebia Therapeutics Inc | 2014-07-28 | director |
Michael D. Clayman Latest Holdings Summary
Michael D. Clayman currently owns a total of 1 stock. Michael D. Clayman owns 824,845 shares of Flexion Therapeutics Inc (FLXN) as of May 26, 2020, with a value of $8 Million.
Latest Holdings of Michael D. Clayman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FLXN | Flexion Therapeutics Inc | 2020-05-26 | 824,845 | 9.12 | 7,522,586 |
Holding Weightings of Michael D. Clayman
Michael D. Clayman Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael D. Clayman has made a total of 1 transactions in Flexion Therapeutics Inc (FLXN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Flexion Therapeutics Inc is the acquisition of 10,256 shares on May 26, 2020, which cost Michael D. Clayman around $99,996.
Insider Trading History of Michael D. Clayman
- 1
Michael D. Clayman Trading Performance
GuruFocus tracks the stock performance after each of Michael D. Clayman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael D. Clayman is 28.45%. GuruFocus also compares Michael D. Clayman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael D. Clayman within 3 months outperforms 9 times out of 16 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael D. Clayman's insider trading performs compared to the benchmark.
Performance of Michael D. Clayman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.14 | | | | | |
| Relative Return to S&P 500(%) | 15.02 | | | | | |
Michael D. Clayman Ownership Network
Ownership Network List of Michael D. Clayman
Ownership Network Relation of Michael D. Clayman
Michael D. Clayman Owned Company Details
What does Flexion Therapeutics Inc do?
Who are the key executives at Flexion Therapeutics Inc?
Michael D. Clayman is the director & President and CEO of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , Chief Strategy Officer Christina Willwerth , and General Counsel Mark S. Levine .
Flexion Therapeutics Inc (FLXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Flexion Therapeutics Inc Insider Transactions
Michael D. Clayman Mailing Address
Above is the net worth, insider trading, and ownership report for Michael D. Clayman. You might contact Michael D. Clayman via mailing address: C/o Flexion Therapeutics, Inc., 10 Mall Road, Suite 301, Burlington Ma 01803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
